Year: 2011
Type: article
Abstract: Over the past decade, a large body of evidence has emerged demonstrating an integration of metabolic and immune response pathways. It is now clear that obesity and associated disorders such as insulin resistance and type 2 diabetes are associated with a metabolically driven, low-grade, chronic inflammatory state, referred to as "metaflammation." Several inflammatory cytokines as well as lipids and metabolic stress pathways can activate metaflammation, which targets metabolically critical organs and tissues including adipocytes and macrophages to adversely affect systemic homeostasis. On the other hand, inside the cell, fatty acid-binding proteins (FABPs), a family of lipid chaperones, as well as endoplasmic reticulum (ER) stress, and reactive oxygen species derived from mitochondria play significant roles in promotion of metabolically triggered inflammation. Here, we discuss the molecular and cellular basis of the roles of FABPs, especially FABP4 and FABP5, in metaflammation and related diseases including obesity, diabetes, and atherosclerosis.
DOI: 10.4061/2011/642612
Institution: Sapporo Medical University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,000
Funders: Suzuken Memorial Foundation, Akiyama Life Science Foundation, Novartis Foundation, Japan Foundation for Applied Enzymology, Tokyo Biochemical Research Foundation, Ministry of Education, Culture, Sports, Science and Technology, Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Ono Medical Research Foundation, Kanae Foundation for the Promotion of Medical Science, NOVARTIS Foundation (Japan) for the Promotion of Science, Japan Diabetes Foundation, Japan Society for the Promotion of Science
OpenAlex ID: W2064343507
